Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
Sawsan Rashdan, Hui Yang, Tri Le, Christopher Selby, David E. Gerber, Carlos A. Álvarez
Topics & Concepts
MedicineLung cancerMedical prescriptionDrugClinical trialInternal medicineRetrospective cohort studyPharmacotherapyClinical endpointCancerVeterans AffairsIntensive care medicinePharmacologyPharmaceutical Practices and Patient OutcomesPharmacogenetics and Drug MetabolismMedication Adherence and Compliance